A Apexigen, Inc.: management transactions · United States · SEC (Form 4) Browse the full management transaction log of Apexigen, Inc., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 25 August 2023 (Retenue fiscale). Among the most active insiders: Sarena Francis Willard. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 25 August 2023
All Executives26 Thresholds0 Prospectus0 Other0
Declarations 26 total
● President and COO · Executives · 23 Aug 2023
31,123 shares @ US$0.3851 52.5% of flow Common Stock SEC:0001209191-23-047439:0
◆ Chief Executive Officer · Executives · 23 Aug 2023
400,000 shares 0Common Stock SEC:0001209191-23-047429:0
● Director · Executives · 23 Aug 2023
10,000 shares Common Stock SEC:0001209191-23-047450:0
● SVP, Finance and Operations · Executives · 23 Aug 2023
15,561 shares @ US$0.3851 57.5% of flow Common Stock SEC:0001209191-23-047441:0
● Director · Executives · 23 Aug 2023
146,383 shares Common Stock SEC:0001209191-23-047454:0
● Chief Financial Officer · Executives · 23 Aug 2023
26,416 shares @ US$0.3851 59.1% of flow Common Stock SEC:0001209191-23-047432:0
● Chief Medical Officer · Executives · 23 Aug 2023
16,354 shares Common Stock SEC:0001209191-23-047436:0
● Chief Medical Officer · Executives · 15 Jun 2023
4,323 shares @ US$0.4911 31.1% of flow Common Stock SEC:0001209191-23-039492:0
● SVP, Finance and Operations · Executives · 15 Jun 2023
2,777 shares @ US$0.4911 13.0% of flow Common Stock SEC:0001209191-23-039497:0
● Chief Executive Officer · Executives · 15 Jun 2023
7,001 shares @ US$0.4911 31.1% of flow Common Stock SEC:0001209191-23-039499:0
● Chief Financial Officer · Executives · 15 Jun 2023
4,504 shares @ US$0.4911 12.7% of flow Common Stock SEC:0001209191-23-039489:0
● President and COO · Executives · 15 Jun 2023
6,917 shares @ US$0.4911 14.8% of flow Common Stock SEC:0001209191-23-039495:0
◆ President and COO · Executives · 23 May 2023
150,000 shares 0Common Stock SEC:0001209191-23-032162:0
◆ SVP, Finance and Operations · Executives · 23 May 2023
75,000 shares 0Common Stock SEC:0001209191-23-032173:0
◆ Chief Financial Officer · Executives · 23 May 2023
150,000 shares 0Common Stock SEC:0001209191-23-032167:0
● Director · Executives · 26 Jan 2023
146,383 shares 0Common Stock SEC:0001209191-23-031779:0
● Chief Financial Officer · Executives · 15 Dec 2022
4,503 shares @ US$1.06 28.2% of flow Common Stock SEC:0001209191-22-061975:0
● Chief Medical Officer · Executives · 15 Dec 2022
4,323 shares @ US$1.06 68.9% of flow Common Stock SEC:0001209191-22-062002:0
● Chief Executive Officer · Executives · 15 Dec 2022
7,001 shares @ US$1.06 68.9% of flow Common Stock SEC:0001209191-22-061966:0
● Chief Operating Officer · Executives · 15 Dec 2022
6,916 shares @ US$1.06 32.7% of flow Common Stock SEC:0001209191-22-062004:0
● SVP, Finance and Operations · Executives · 15 Dec 2022
2,851 shares @ US$1.06 29.5% of flow Common Stock SEC:0001209191-22-062008:0
◆ Chief Operating Officer · Executives · 7 Oct 2022
40,000 shares 0Common Stock SEC:0001209191-22-053349:0
◆ SVP, Finance and Operations · Executives · 7 Oct 2022
16,488 shares 0Common Stock SEC:0001209191-22-053351:0
◆ Chief Financial Officer · Executives · 7 Oct 2022
30,685 shares 0Common Stock SEC:0001209191-22-053342:0
◆ Chief Medical Officer · Executives · 7 Oct 2022
25,000 shares 0Common Stock SEC:0001209191-22-053346:0
25 of 26 declarations
Load more (1 remaining)